HTA186 Cost-Effectiveness Analysis of Tirbanibulin for the Treatment of Actinic Keratosis From a Scottish NHS Perspective
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1644
https://www.valueinhealthjournal.com/article/S1098-3015(22)03849-9/fulltext
Section Title :
Section Order :
11197
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03849-9&doi=10.1016/j.jval.2022.09.1644